UVE shareholder files Rule 144 notice to sell 25,000 shares

A holder of UVE common stock filed an amended notice under Rule 144 to sell 25,000 shares through Wells Fargo Clearing Services on or about 12/30/2025 on the NYSE, with an aggregate market value of $844,398.16.

Rhea-AI Filing Summary

A holder of UVE common stock filed an amended notice under Rule 144 to sell 25,000 shares through Wells Fargo Clearing Services on or about 12/30/2025 on the NYSE, with an aggregate market value of $844,398.16. The filing notes that 28,048,881 shares of the same class were outstanding. It also reports that the Stephen Donaghy Trust previously sold 25,000 common shares of UVE on 12/29/2025 for gross proceeds of $851,779.94. The seller represents that they do not know of any material adverse, non‑public information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the UVE Form 144/A filing disclose?

The filing discloses that a holder of UVE common stock has filed an amended notice under Rule 144 to sell 25,000 shares through Wells Fargo Clearing Services on or about 12/30/2025 on the NYSE, with an aggregate market value of $844,398.16.

How many UVE shares are planned to be sold and what is their market value?

The notice covers the proposed sale of 25,000 UVE common shares with an aggregate market value of $844,398.16 as provided in the filing.

How many UVE shares are outstanding according to this Form 144/A?

The filing states that there are 28,048,881 UVE common shares outstanding for the class of securities referenced in the proposed sale.

What prior UVE share sales by the same seller are reported?

The filing reports that the Stephen Donaghy Trust sold 25,000 common shares of UVE on 12/29/2025, generating $851,779.94 in gross proceeds during the past three months.

Who is the broker for the planned UVE share sale under Rule 144?

The proposed sale of 25,000 UVE common shares is listed as being handled by Wells Fargo Clearing Services, located at 1 N. Jefferson Ave., St. Louis, MO 63103, with the shares to be sold on the NYSE.

What representation does the seller make about information on UVE?

The person for whose account the securities are to be sold represents by signing that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/30/2025 - 03:20 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK	0001492959
Filer CCC	XXXXXXXX
Previous Accession Number Of The Filing	0001492959-25-000004
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer	UNIVERSAL INSURANCE HOLDINGS, INC.
SEC File Number	001-33251
Address of Issuer	1110 W. COMMERCIAL BLVD. SUITE 100 FORT LAUDERDALE FLORIDA 33309
Phone	954-958-1200
Name of Person for Whose Account the Securities are To Be Sold	Donaghy Stephen
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Wells Fargo Clearing Services 1 N. Jefferson Ave. St. Louis MO 63103	25000	844398.16	28048881	12/30/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/08/2013	Open Market Purchase	Open Market			25000	04/08/2013	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Stephen Donaghy Trust 1110 W. Commercial BLVD. Suite 100 Fort Laurderdale FL 33309	Common Shares of UVE	12/29/2025	25000	851779.94

144/A: Remarks and Signature

Remarks	Amended filing to correct previous acquisition information. Shares were sold by the Stephen Donaghy Trust, Stephen Donaghy is the TTEE and an officer/Director of UVE.
Date of Notice	12/30/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Stephen Donaghy
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)